The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Bumrungrad Hospital PCL 9-Day RSI Related Terms
BUGDF vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bumrungrad Hospital PCL (BUGDF) has a 9-Day RSI of 11.88 as of Jun. 28, 2026. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #608 out of 699 companies in the Healthcare Providers & Services industry, placing it in the top 87%.
Is Bumrungrad Hospital PCL's 9-Day RSI too high?
Bumrungrad Hospital PCL's current 9-Day RSI is 11.88. The Healthcare Providers & Services industry median 9-Day RSI is 47.75. Bumrungrad Hospital PCL's value of 11.88 is 75.1% below this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #608 out of 699 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Bumrungrad Hospital PCL has a GF Score™ of 100/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #608 out of 699 companies for 9-Day RSI. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median 9-Day RSI is 47.75. Bumrungrad Hospital PCL's value of 11.88 is 75.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 47.75, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current 9-Day RSI of 11.88 is 75.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 47.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current 9-Day RSI is 11.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current 9-Day RSI of 11.88. The stock's GF Value™ is $5.79, compared to a current price of $4.75 — trading 18% below its estimated fair value. The current 9-Day RSI is 11.88 and 75.1% below the Healthcare Providers & Services industry median of 47.75. Bumrungrad Hospital PCL's overall GF Score™ is 100/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current 9-Day RSI is 11.88 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be undervalued.
The current stock price of $4.75 is trading 18% below its estimated GF Value™ of $5.79.
Key valuation signals for BUGDF:
9-Day RSI: 11.88
GF Value™: $5.79 vs. price of $4.75 (18% below fair value)
Industry Position: 75.1% below the Healthcare Providers & Services median (#608 of 699)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
100GF Score
Get the complete analysis for BUGDF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 